During this complimentary live webinar we will cover:
- Overview of Supreme Court cases prior to Myriad regarding patentable subject matter, including Bilski and Prometheus
- Discuss the holding and rationale, including what remains patent-eligible, what clearly is not, and what remains unknown
- Implications to companies that hold patents related to nucleic acids or other products of nature
Register early for a guaranteed spot. Space is limited.
For more information on this topic, click here to read the Baker Donelson Alert.